|   View web version
Today's Geriatric Medicine e-Newsletter
Subscribe or Renew
Digital Edition
July 2022 Connect with us Facebook Twitter Sign up  |  Archive  |  Advertise
Editor's e-Note
According to findings published in The Lancet, a new combination therapy can improve outcome and prolong life for patients with prostate cancer. The Cedars-Sinai Cancer study enrolled 1,716 patients and divided them in three groups. Those in the group receiving salvage prostate bed radiotherapy had a median five-year survival of 71%. Members of the group receiving the standard radiation treatment combined with androgen deprivation therapy had a median five-year survival of 81%. And 87% of those in the third group, which received salvage prostate bed radiotherapy, androgen deprivation therapy and pelvic lymph node radiation, were free from progression of cancer for five years.

In addition to reading our e-newsletter, be sure to visit Today’s Geriatric Medicine’s website at, where you’ll find news and information that’s relevant and reliable. We welcome your feedback at Follow Today’s Geriatric Medicine on Facebook and Twitter too.

— Kate Jackson, editor
e-News Exclusive
Helping Prostate Cancer Patients Live Longer

Cedars-Sinai Cancer Study Shows Hormone Therapy, Plus Pelvic Lymph Node Treatment, Improves Survival

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.

The study also shows that patients with prostate cancer who didn’t receive androgen deprivation therapy—and who did not receive pelvic lymph node radiation—had a five-year survival of 70%.

“We can now confirm that pelvic lymph node treatment used together with androgen deprivation therapy, or even used as a stand-alone treatment option, greatly improves outcomes in patients with postoperative prostate cancer,” says Howard Sandler, MD, chair of the department of radiation oncology at Cedars-Sinai Cancer and senior author of the study. “These findings are an encouraging step forward, both for the medical community and for the patients and their loved ones seeking curative treatment options.”

The international Phase III clinical trial that served as the basis of The Lancet study enrolled 1,716 patients between March 31, 2008, and March 30, 2015. Enrollees were separated into three groups.

Group one received salvage prostate bed radiotherapy—a standard radiation targeted to the area in which the prostate used to exist before its surgical removal. These patients had a median five-year survival of 71%.

The second group received the standard radiation treatment, in combination with androgen deprivation therapy. They had a median five-year survival of 81%.

The third group received salvage prostate bed radiotherapy, androgen deprivation therapy, and pelvic lymph node radiation. These patients had a five-year freedom from progression of just over 87%.

Full story »
Recently in Today's Geriatric Medicine
Targeted Exercise Reduces Risk
Targeted exercise programs are the most effective intervention to prevent falls in older adults. Read more »

How to Prepare for the 3G Shutoff
Older adults who rely on medical emergency devices that still use 3G networks need to be prepared for the shutoff. Read more »

Ageism and Us — More to Consider
To determine whether they’re correctly working with older adult clients, social workers and geriatric professionals need to ask themselves some tough questions. Read more »
Other Geriatrics News
Omicron’s Toll on Older Adults
Despite their high rates of vaccination against COVID-19, older adults died at much higher rates during last winter’s Omicron wave than they did the year before, according to a report by The New York Times indicating that older people bear the brunt of the deaths caused by the virus.

Research Sheds Light on What Kind of Cell Dies During Parkinson’s Disease
After categorizing 10 types of human brain cells in the substantia nigra, researchers from Broad Institute of Harvard and MIT, Stanley Center for Psychiatric Research in Cambridge, Massachusetts, have learned that only one type is especially susceptible to destruction—a finding that may shed light on how the disease develops and how it might be conquered.

Scientists Identify a Brain Boost From Cranberries
Studying the effects of the daily consumption of freeze-dried cranberry powder roughly equivalent to roughly a cup of cranberries by individuals 50 to 80 years old, scientists from the University of East Anglia in the United Kingdom have found that the berries may lower bad cholesterol, significantly boost memory, and decrease the risk of dementia. Science Daily reports that the benefits were evident in only 12 weeks.

An Upside to Food Allergies
A surprise finding of a recent study aimed to explore whether self-reported asthma and/or other allergic disease were inked with SARS-Cov-2 infection and household transmission. The research, published in the Journal of Allergy and Clinical Immunology and funded by the National Institutes of Health, found that self-reported doctor-diagnosed food allergy was linked to a 50% lower risk of infection with the virus.
In this e-Newsletter
Products & Services
Equiva’s Mobile Connect
Adding to its suite of digital patient engagement solutions, Equiva offers its Mobile Connect solution to affordably deliver patient cohort-specific education and resources via mobile app. The solution enhances the company’s health relationship management platform, an integrated omnichannel solution for collaborate, hyper-targeted digital health engagement. With Equiva Mobile Connect, the health care organization, or an individual unit, department, or clinic, can select specific education materials, support resources, and information to be presented via the app to align with targeted population-based care objectives. Learn more »

Burnout Prevention
SE Healthcare, a company dedicated to advancing health care practices, has partnered with the American Nurses Association to allow its members access to SE Healthcare’s innovative burnout prevention program. The web-based platform—the Enrichment Center—offers educational content and skill-based tools to prevent career burnout. It houses a collection of videos and audios and includes 22 contact hours, with content focusing on the most common stressors for nurses, and offers targeted mitigation tactics, culminating in the development of a personal burnout prevention strategy. Learn more »
Set up Job Alerts and create your online Résumé
to let potential employers find you today!
Advertising Opportunities
Have a product or service you want to market to geriatricians, other physicians and the geriatric care team of professionals who treat aging patients? Are you a recruiter looking to fill the many geriatric professional openings within a facility, physician practice, or academic institution? Then utilize the reach of Today's Geriatric Medicine to accomplish your marketing goals and fill any open positions.

A resource for professionals looking for new opportunities, as well as those physicians just curious to see what's out there, our Physician Recruitment Center gives physician recruiters a powerful tool to fill partnership opportunities, academic appointments, and hospital staff positions. To support your product marketing or recruiting needs, email our experienced account executives today at for more information or call 800-278-4400!